Beyond Embryonic Stem Cells

Presented by

Kenneth Aldrich, CEO, International Stem Cell Corporation

About this talk

With the announcement of a pending change in Federal rules governing stem cell research, Embryonic Stem Cells have dominated the news in recent days. However, there are other methods of producing pluripotent stem cells that provide exciting alternatives and opportunities to advance human therapy that go beyond what is likely from embryonic stem cells. These include Parthenogenic Stem Cells (made without the use or destruction of human embryos) that may offer a solution to the problem of immune rejection; Induced Pluripotent Stem cells made from skin or other tissue, including possibly tissue from the patient; and Somatic Cell Nuclear Transfer, which has been largely forgotten, but offers very interesting possibilities. This presentation will discuss these and their various advantages and disadvantages as compared to each other and embryonic stem cells.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (35)
Subscribers (1913)
This channel will feature presentations by influential representatives from academia, producers, healthcare providers, payers and regulators to explore hot topics in healthcare. Thought leaders will debate the scientific, economical and political challenges and propose viable solutions to optimizing healthcare and medicine.